Back
Corvus Pharmaceuticals Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
56
CRVS
Corvus Pharmaceuticals
Last Price:
8.18
Seasonality Move:
-6.15%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Corvus Pharmaceuticals Price Quote
$8.18
-0.01 (-3.99%)
(Updated: November 16, 2024 at 5:13 AM ET)
Corvus Pharmaceuticals Key Stats
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Day range:
$7.78 - $8.51
52-week range:
$1.30 - $10.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
10%
Volume:
2.3M
Avg. volume:
986.5K
1-year change:
442.38%
Market cap:
$512.3M
Revenue:
$0
EPS:
$-0.44
How Much Does Corvus Pharmaceuticals Make?
Data Unavailable
Is Corvus Pharmaceuticals Growing As A Company?
Data Unavailable
Corvus Pharmaceuticals Stock Price Performance
-
Did Corvus Pharmaceuticals Stock Go Up Last Month?
Corvus Pharmaceuticals share price went up by 21.88% last month -
Did CRVS's Share Price Rise Over The Last Year?
CRVS share price rose by 442.38% over the past 1 year
What Is Corvus Pharmaceuticals 52-Week High & Low?
-
What Is Corvus Pharmaceuticals’s 52-Week High Share Price?
Corvus Pharmaceuticals has traded as high as $10.00 over the past 52 weeks -
What Is Corvus Pharmaceuticals’s 52-Week Low Share Price?
Corvus Pharmaceuticals has traded as low as $1.30 over the past 52 weeks
Corvus Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Corvus Pharmaceuticals?
-
How Much Debt Does Corvus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Corvus Pharmaceuticals Have?
Cash and short term investments quarterly total is $47.2M -
What Is Corvus Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.82
Is Corvus Pharmaceuticals Cash Flow Positive?
-
What Is CRVS Cash Flow From Operations?
Cash flow from operations (TTM) is -$21.2M -
What Is Corvus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $30.7M -
What Is Corvus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3M
Corvus Pharmaceuticals Return On Invested Capital
Data Unavailable
Corvus Pharmaceuticals Earnings Date & Stock Price
-
What Is Corvus Pharmaceuticals's Stock Price Today?
A single share of CRVS can be purchased today for 8.19 -
What Is Corvus Pharmaceuticals’s Stock Symbol?
Corvus Pharmaceuticals trades on the nasdaq under the ticker symbol: CRVS -
When Is Corvus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Corvus Pharmaceuticals is scheduled on March 19, 2025 -
When Is CRVS's next ex-dividend date?
Corvus Pharmaceuticals's next ex-dividend date is November 16, 2024 -
How To Buy Corvus Pharmaceuticals Stock?
You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Corvus Pharmaceuticals Competitors
-
Who Are Corvus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Corvus Pharmaceuticals or are related in some way:
Corvus Pharmaceuticals Dividend Yield
-
What Is CRVS Dividend Yield?
Corvus Pharmaceuticals’s dividend yield currently is 0% -
What Is Corvus Pharmaceuticals’s Payout Ratio?
Corvus Pharmaceuticals’s payout ratio is 0% -
When Did Corvus Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Corvus Pharmaceuticals’s Dividend Per Share?
Corvus Pharmaceuticals pays a dividend of $0.00 per share
Corvus Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -400% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 15.75 |
| Upside from Last Price: | 92.31% |